The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...

Critically, they find that immune challenge is ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating ...

AbbVie (NYSE: ABBV) today announced positive topline results from its pivotal Phase 3 TEMPO-2 trial evaluating investigational tavapadon as a flexible-dose monotherapy in early Parkinson's disease.

Objective To investigate the effect on survival of treatment with memantine in patients with dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). Methods 75 patients with DLB ...

OBJECTIVES To assess long term (24 months) effects of the Lee Silverman voice treatment (LSVT®), a method designed to improve vocal function in patients with Parkinson's disease. METHODS Thirty three ...

and bradykinesia - three prominent symptoms of the disease. Regeneron's pipeline doesn't currently include a clinical-stage treatment for Parkinson's. but it is working on drugs for other ...

BTL Medical Ireland’s new-gen tech is transforming treatments for stroke, spinal cord injuries, chronic health concerns and ...